Skip to main content
Clinical Trials/JPRN-UMIN000000768
JPRN-UMIN000000768
Not yet recruiting
未知

Clinical study on tissue adhesion preventive devices Trehalose based novel devices for postoperative tissue adhesions - Clinical study on tissue adhesion preventive devices

The University of Tokyo Hospital Department of Obstetrics & Gynecology0 sites30 target enrollmentJuly 16, 2007

Overview

Phase
未知
Intervention
Not specified
Conditions
terine leiomyoma, ovarian tumor, tubal adhesion, caesarotomy
Sponsor
The University of Tokyo Hospital Department of Obstetrics & Gynecology
Enrollment
30
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 16, 2007
End Date
August 1, 2008
Last Updated
2 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
The University of Tokyo Hospital Department of Obstetrics & Gynecology

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1 Pregnant women, except for cesarean section patients 2 Patients who have received intravenous drip injections and, or perfusates containing dextran, heparin, corticosteroids or nonsteroidal antiinflammatory drugs. 3 Patients who chronically need to receive corticosteroids, or patients who are administered corticosteroids and, or nonsteroidal antiinflammatory drugs within 24 hours prior to surgeries. 4 Patients who have been treated with Interseeds or PRECLUDE surgical membranes or have received other antiadhesion treatments. 5 Patients in the physical conditions that can affect evaluation of safety and efficacy of the present device or Seprafilm. 6 Patients with histories of severe drug allergies. 7 Patients who have received other research products that might affect evaluations of safety and efficacy of the present device during the trial period. 8 Patients with active pelvic inflammatory diseases or peritonitis. 9 Patients who have had open abdominal operations. 10 Patients whose SGOT, SGPT or bilirubin level is more than 20 percent higher than each upper limit. 11 Patients whose BUN and creatinine level are more than 30 percent higher than each upper limit. 12 Patients with severe diabetes mellitus with over 8 percent of HbA1c. 13 Patients who are judged to be inappropriate for the study by doctors in their charge

Outcomes

Primary Outcomes

Not specified

Similar Trials